How has lockdown affected diabetes management?
The COVID-19 pandemic has temporarily modified our lifestyles. One factor that has been particularly affected is mobility, which is directly relate...
News from Institute of Digestive and Metabolic Diseases
How to shop more healthily?
Interview with Cristina Montserrat, a dietician/nutritionist at Hospital Clínic who specialises in metabolic diseases.
The Clínic-IDIBAPS participates in the international guidelines for the management of ascites, kidney infections and the renal complications of liver cirrhosis
Professionals from the Hospital Clínic-IDIBAPS and CIBEREHD participated in the preparation of the international guidelines produced by the America...
Researchers from the Hospital Clínic-IDIBAPS participate in AASLD’s new guidelines on vascular liver diseases
Researchers from the Hospital Clínic-IDIBAPS and CIBEREHD participated in the new guidelines made by the American Association for the Study of Live...
Factors related to improvement are established in patients with alcoholic liver cirrhosis on a transplant waiting list
A study led by researchers from the Clínic-IDIBAPS and the CIBEREHD and published in the Journal of Hepatology shows that up to 9% of patients with...
How does sleep duration affect people with type 2 diabetes mellitus?
A study shows that sleep duration in people with type 2 diabetes mellitus is associated with an increased risk of cardiovascular mortality. Sleepin...
Two articles review current knowledge on the management of hepatocellular carcinoma
Clínic-IDIBAPS researchers have coordinated two review articles on hepatocellular carcinoma (HCC), the most common type of liver cancer, in which t...
Dr. Sabela Lens receives the Rising Star award for her professional career
Dr. Sabela Lens, who was a winner of the 2020 Rising Star Award of the Spanish Society of Digestive Disease (SEPD), was given the United European G...
Factors associated with satisfactory withdrawal of antiviral treatment in chronic hepatitis B described
Researchers of the IDIBAPS-Hospital Clínic research group Viral, toxic and metabolic liver diseases and CIBEREHD have published a study in the Jour...
Continuous glucose monitoring: is there an age limit?
The improvement in controlling and treating diabetes mellitus type 1 has meant better survival rates in those affected by this disease. This is why...